Fluorinated Compounds Against Mycobacterium tuberculosis

被引：8
|
作者：
Boechat, Nubia [1 ]
Bastos, Monica M. [1 ]
机构：
[1] Fiocruz MS, Inst Tecnol Farmacos Farmanguinhos, Dept Sintese Farmacos, BR-21041250 Rio De Janeiro, RJ, Brazil
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2013年 / 13卷 / 22期
关键词：
Organofluorine; fluoroquinolones; trifluoromethyl; nitroimidazoles; N-fluorobenzoxazolidinones; Mycobacterium tuberculosis; IN-VITRO ANTIMYCOBACTERIAL; MULTIDRUG-RESISTANT; ANTITUBERCULOSIS ACTIVITY; QUINOXALINE 1,4-DIOXIDES; BACTERICIDAL ACTIVITY; POTENTIAL TREATMENT; DERIVATIVES; ANALOGS; DRUG; ANTIBACTERIAL;
D O I：
10.2174/15680266113136660204
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Tuberculosis is a severe infectious disease currently being treated with drugs that were developed more than 40 years ago. In recent years, the emergence of resistant Mycobacterium tuberculosis strains, as well as co-infection with the AIDS virus, has caused global concern about the evolution of the disease. Thus, the search for new drugs has become a necessity and a great challenge. Fluorine is a strategic element that is very useful in medicinal chemistry for its great influence on the biological activity of substances. This review highlights the importance of fluorinated molecules that are currently in clinical use or pre-clinical phases of development. Further, some substances in the prototype development stage are cited, which potentially represent future alternatives for the treatment of tuberculosis.
引用
收藏
页码：2885 / 2904
页数：20
相关论文
共 50 条
  • [21] Novel thiourea derivatives against Mycobacterium tuberculosis: synthesis, characterization and molecular docking studies
    Kutlu, Emine
    Emen, Fatih Mehmet
    Yildirim, Kuebra
    Atas, Cemilenur
    Demirdogen, Ruken Esra
    Yesilkaynak, Tuncay
    Kinayturk, Neslihan Kaya
    Simsek, Ece
    Coban, Ahmet Yilmaz
    PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 2023, 198 (10) : 844 - 853
  • [22] In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters
    Xu, J.
    Lu, Y.
    Fu, L.
    Zhu, H.
    Wang, B.
    Mdluli, K.
    Upton, A. M.
    Jin, H.
    Zheng, M.
    Zhao, W.
    Li, P.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (08) : 1119 - 1125
  • [23] α-pyrones and their hydroxylated analogs as promising scaffolds against Mycobacterium tuberculosis
    Bhat, Zubair Shanib
    Rather, Muzafar Ahmad
    Syed, Khalid Yousuf
    Ahmad, Zahoor
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (17) : 2053 - 2067
  • [24] Potent cationic antimicrobial peptides against Mycobacterium tuberculosis in vitro
    Silva, Sara
    Santos-Silva, Anabela
    Correia da Costa, Jose Manuel
    Vale, Nuno
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 19 : 132 - 135
  • [25] Biological and Biochemical Evaluation of Isatin-Isoniazid Hybrids as Bactericidal Candidates against Mycobacterium tuberculosis
    Johansen, Matt D.
    Shalini
    Kumar, Sumit
    Raynaud, Clement
    Quan, Diana H.
    Britton, Warwick J.
    Hansbro, Philip M.
    Kumar, Vipan
    Kremer, Laurent
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
  • [26] Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis
    Anand, R. S.
    Somasundaram, Sulochana
    Doble, Mukesh
    Paramasivan, C. N.
    BMC STRUCTURAL BIOLOGY, 2011, 11
  • [27] Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity
    Wavhale, Ravindra D.
    Martis, Elvis A. F.
    Ambre, Premlata K.
    Wan, Baojie
    Franzblau, Scott G.
    Iyer, Krishna R.
    Raikuvar, Kavita
    Macegoniuk, Katarzyna
    Berlicki, Lukasz
    Nandan, Santosh R.
    Coutinho, Evans C.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (17) : 4835 - 4844
  • [28] Cardamom Derived Phytochemicals against Mycobacterium tuberculosis Causing Tuberculosis
    Patra, Bijan Pumar
    Palai, Bapujee
    Mishra, Sarthak Siddhant
    Jha, Sunil
    Bhattacharyay, Dipankar
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (06) : 132 - 135
  • [29] Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model
    Rey-Jurado, Emma
    Tudo, Griselda
    Soy, Dolors
    Gonzalez-Martin, Julian
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (06) : 524 - 530
  • [30] Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones
    Li, Peng
    Wang, Bin
    Zhang, Xinwei
    Batt, Sarah M.
    Besra, Gurdyal S.
    Zhang, Tingting
    Ma, Chen
    Zhang, Dongfeng
    Lin, Ziyun
    Li, Gang
    Huang, Haihong
    Lu, Yu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 160 : 157 - 170
12345